PBH Return on Tangible Equity | PRESTIGE CONSUMER HEALTHCARE INC.

PRESTIGE CONSUMER HEALTHCARE INC. (PBH) Return on Tangible Equity

2026-06-30: Return Tang Equity 20.05%.
2026-03-31: Return Tang Equity 16.54%.
2025-12-31: Return Tang Equity 17.14%.
2025-09-30: Return Tang Equity 17.52%.

Complete source-backed return tang equity history.

Available history: 2010-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	20.05%
2026-03-31	16.54%
2025-12-31	17.14%
2025-09-30	17.52%
2025-06-30	18.17%
2025-03-31	18.68%
2024-12-31	19.08%
2024-09-30	19.47%
2024-06-30	20.44%
2024-03-31	21.49%
2023-12-31	-8.82%
2023-09-30	-9.66%
2023-06-30	-10.74%
2023-03-31	-11.02%
2022-12-31	23.14%
2022-09-30	24.89%
2022-06-30	25.52%
2022-03-31	26.38%
2021-12-31	26.30%
2021-09-30	26.61%
2021-06-30	27.52%
2021-03-31	28.08%
2020-12-31	30.49%
2020-09-30	32.96%
2020-06-30	34.52%
2020-03-31	37.27%
2019-12-31	-9.47%
2019-09-30	-10.90%
2019-06-30	-12.35%
2019-03-31	-12.64%
2018-12-31	17.42%
2018-09-30	106.26%
2018-06-30	120.30%
2018-03-31	126.75%
2017-12-31	130.10%
2017-09-30	-392.10%
2017-06-30	-165.77%
2017-03-31	-64.76%
2016-12-31	30.66%
2016-09-30	37.23%
2016-06-30	49.53%
2016-03-31	122.63%
2015-12-31	57.53%
2015-09-30	71.34%
2015-06-30	76.24%
2015-03-31	103.41%
2014-12-31	71.85%
2014-09-30	67.82%
2014-06-30	25.02%
2014-03-31	28.87%
2013-12-31	32.90%
2013-09-30	37.92%
2013-06-30	34.74%
2013-03-31	36.22%
2012-12-31	28.97%
2012-09-30	33.46%
2012-06-30	40.15%
2012-03-31	16.25%
2011-12-31	17.60%
2011-09-30	15.27%
2011-06-30	15.43%
2011-03-31	14.12%

Annual Return Tang Equity

Date	Return Tang Equity
2026-03-31	16.54%
2025-03-31	18.68%
2024-03-31	21.49%
2023-03-31	-11.02%
2022-03-31	26.38%
2021-03-31	28.08%
2020-03-31	37.27%
2019-03-31	-12.64%
2018-03-31	126.75%
2017-03-31	-64.76%
2016-03-31	122.63%
2015-03-31	103.41%
2014-03-31	28.87%
2013-03-31	36.22%
2012-03-31	16.25%
2011-03-31	14.12%
2010-03-31	14.76%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
OCULAR THERAPEUTIX, INC (OCUL)	United States	$2.159B	-7.15
Aurinia Pharmaceuticals Inc. (AUPH)		$2.207B	7.18
Bausch Health Companies Inc. (BHC)		$2.113B	-1.68
Braveheart Bio, Inc. (BRVE)	United States	$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
Zai Lab Ltd (ZLAB)		$2.241B	-113.34
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05